Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Five Prime Therapeutics Inc (NASDAQ:FPRX)

19.25
Delayed Data
As of Sep 04
 +0.05 / +0.26%
Today’s Change
11.29
Today|||52-Week Range
28.47
-28.70%
Year-to-Date

Today’s Trading

Previous close19.20
Today’s open18.91
Day’s range18.79 - 19.60
Volume195,660
Average volume (3 months)378,248
Market cap$495.5M
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)+65.77%
Earnings growth (this year)-34.20%
Earnings growth (next 5 years)--
Revenue growth (last year)+39.45%
P/E ratioNM
Price/Sales29.29
Price/Book4.89

Competitors

 Today’s
change
Today’s
% change
NDRMNeuroderm Ltd+0.08+0.35%
AEGRAegerion Pharmaceuti...-0.06-0.34%
PFNXPfenex Inc-0.03-0.15%
CYADCelyad SA-2.27-4.56%
Data as of 4:02pm ET, 09/04/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)-$0.95
Annual revenue (last year)$19.2M
Annual profit (last year)-$37.4M
Net profit margin-194.60%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Lewis T. Williams
Chief Financial Officer &
Senior Vice President
Marc L. Belsky
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers